English | Español
Patient Daily | Jan 19, 2026

Aurora Therapeutics launches with $16M seed round aiming at scalable personalized gene therapy
Patient Daily | Jan 19, 2026

FDA removes special risk program for CAR T therapies amid calls for better side effect management
Patient Daily | Jan 19, 2026

Early-stage biotech funding drops as investors shift focus to late-stage assets
Patient Daily | Jan 19, 2026

How businesses can link digital campaigns with in-store revenue
Patient Daily | Jan 19, 2026

Veradermics and Eikon Therapeutics announce plans for initial public offerings
Patient Daily | Jan 19, 2026

Novartis enters global Alzheimer’s partnership with SciNeuro Pharmaceuticals
Patient Daily | Jan 19, 2026

Flagship CEO warns US risks falling behind China amid cuts to science funding
Patient Daily | Jan 19, 2026

AbbVie licenses RemeGen's cancer drug candidate for nearly $5 billion

Trending
+ Regulatory
B. D. Benavides | Mar 18, 2026

Taxpayer advocate: Instead of improving product safety, litigation can result in the ‘opposite because runaway legal costs deter innovation'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
+ Regulatory
Patient Daily | Mar 20, 2026

Neurosurgeon DiGiorgio on 340B: '340B also takes money from taxpayers and makes everyone’s health insurance more expensive'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

FDA rejects REGENXBIO’s Hunter syndrome therapy as Denali awaits decision on rival drug